A GRIP-1–EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a-Reference-Cited by-同舟云学术

A GRIP-1–EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a

Published:2022-10-29 Issue:49 Volume:41 Page:5223-5237
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Song Yang-Liu,Yang Ming-Hui,Zhang Si,Wang Hao,Kai Kun-Lun,Yao Chun-Xia,Dai Fei-Fei,Zhou Meng-Jiao,Li Jin-Biao,Wei Zhi-Ru,Yin Zhongnan,Zhu Wei-Guo,Xue Lixiang^ORCID,Zang Ming-Xi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-022-02521-5.pdf

Reference43 articles.

1. Chen C, Dorado Garcia H, Scheer M, Henssen AG. Current and future treatment strategies for rhabdomyosarcoma. Front Oncol. 2019;9:1458.

2. Missiaglia E, Shepherd CJ, Aladowicz E, Olmos D, Selfe J, Pierron G, et al. MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas. Cancer Lett. 2017;385:251–60.

3. Hanna JA, Garcia MR, Lardennois A, Leavey PJ, Maglic D, Fagnan A, et al. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. Oncogene 2018;37:1991–2007.

4. Pandey PR, Chatterjee B, Olanich ME, Khan J, Miettinen MM, Hewitt SM, et al. PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma. J Pathol. 2017;241:626–37.

5. Megiorni F. Epigenetics in rhabdomyosarcoma: cues to new biomarkers and targeted therapies. EBioMedicine. 2020;52:102673.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muscle stem cell dysfunction in rhabdomyosarcoma and muscular dystrophy;Current Topics in Developmental Biology;2024

2. Non-canonical functions of EZH2 in cancer;Frontiers in Oncology;2023-08-18

3. Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma;Cancers;2023-05-18